Sarepta Therapeutics Inc (SRPT)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 319,099 | 150,343 | 139,989 | 97,049 | 63,382 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $319,099K ÷ $—K
= —
The payables turnover ratio for Sarepta Therapeutics Inc has been consistently reported as not available for the years 2020 to 2024. This might indicate that the company does not disclose or calculate this ratio in their financial statements. The payables turnover ratio is a measure of how efficiently a company manages its payments to suppliers and vendors. Without this data, it is challenging to assess Sarepta's ability to pay its short-term obligations and its relationship with its suppliers. It is advisable for stakeholders to inquire further about the company's payables turnover practices for a more in-depth financial analysis.
Peer comparison
Dec 31, 2024